SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001102624-13-000798
Filing Date
2013-07-10
Accepted
2013-07-10 08:16:56
Documents
5
Period of Report
2013-07-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 THERAVANCE, INC. 8-K theravance8k.htm 8-K 27586
2 EXHIBIT 99.1 exh99_1.htm EX-99.1 42039
3 IMAGE image1.jpg GRAPHIC 2705
4 IMAGE image2.jpg GRAPHIC 3191
5 IMAGE image3.jpg GRAPHIC 2900
  Complete submission text file 0001102624-13-000798.txt   83299
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 13960688
SIC: 2834 Pharmaceutical Preparations